CIK: 0001544773
Total reported value
$7.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | KPTIEUR | Karyopharm Therapeutics INC | Stock-Other | 10.27% | — | +17.19% | |
| 2 | UTHR | United Therapeutics CORP | Stock-Healthcare | 9.53% | — | +46.90% | |
| 3 | AUPH | Aurinia Pharmaceuticals INC | Stock-Other | 7.47% | — | +4.28% | |
| 4 | CCXIEUR | Chemocentryx INC | Stock-Other | 6.87% | — | +20.83% | |
| 5 | SRPT | Sarepta Therapeutics INC | Stock-Healthcare | 6.00% | — | +131.13% | |
| 6 | KDMN | Kadmon Holdings INC | Stock-Other | 4.87% | — | -0.21% | |
| 7 | OMER | Omeros CORP | Stock-Other | 4.46% | — | +40.18% | |
| 8 | CDNA | Caredx INC | Stock-Other | 4.33% | — | +25.39% | |
| 9 | AKBA | Akebia Therapeutics INC | Stock-Other | 4.02% | — | — | |
| 10 | EPZMEUR | Epizyme INC | Stock-Other | 3.82% | — | -23.26% | |
| 11 | QURE | uniQure N.V. | Stock-Other | 3.65% | — | +11.15% | |
| 12 | ASMB | Assembly Biosciences, Inc. | Stock-Other | 3.51% | — | +69.06% | |
| 13 | PRNB | Principia Biopharma INC | Stock-Other | 3.05% | — | — | |
| 14 | CYTK | Cytokinetics INC | Stock-Healthcare | 3.01% | — | — | |
| 15 | AXGN | Axogen INC | Stock-Other | 2.76% | — | +19.41% | |
| 16 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 2.58% | — | — | |
| 17 | ✓ | Stock-Other | 2.56% | — | +21.46% | ||
| 18 | RTRXEUR | Retrophin INC | Stock-Other | 2.51% | — | — | |
| 19 | CHRS | Coherus Oncology INC | Stock-Other | 2.44% | — | — | |
| 20 | KRYS | Krystal Biotech INC | Stock-Healthcare | 2.11% | — | +221.21% | |
| 21 | ITCIEUR | Intra-cellular Therapies INC | Stock-Other | 1.89% | — | -16.22% | |
| 22 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 1.67% | — | — | |
| 23 | ✓ | Liminal Biosciences INC | Stock-Other | 1.64% | — | — | |
| 24 | BLU | Bellus Health INC | Stock-Other | 1.19% | — | — | |
| 25 | OXLC | Oxford Lane Capital Corp. | Stock-Other | 0.86% | — | -47.35% | |
| 26 | OPHTEUR | Iveric Bio INC | Stock-Other | 0.81% | — | -8.05% | |
| 27 | ADMA | Adma Biologics INC | Stock-Healthcare | 0.73% | — | -34.52% | |
| 28 | ✓ | Axovant Gene THE | Stock-Other | 0.66% | — | — | |
| 29 | OVID | Ovid Therapeutics INC | Stock-Other | 0.57% | — | -10.66% | |
| 30 | BEATEUR | Biotelemetry INC | Stock-Other | 0.14% | — | -68.25% | |
| 31 | APLSUSD | Apellis Pharmaceuticals INC | Stock-Other | 0.02% | — | -92.59% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | UTHR | United Therapeutics CORP | +4.6% | +46.90% | Add |
| 2 | SRPT | Sarepta Therapeutics INC | +3.2% | +131.13% | Add |
| 3 | KPTIEUR | Karyopharm Therapeutics INC | +3.1% | +17.19% | Add |
| 4 | CCXIEUR | Chemocentryx INC | +2.3% | +20.83% | Add |
| 5 | OMER | Omeros CORP | +1.7% | +40.18% | Add |
| 6 | CDNA | Caredx INC | +1.5% | +25.39% | Add |
| 7 | KRYS | Krystal Biotech INC | +1.4% | +221.21% | Add |
| 8 | ASMB | Assembly Biosciences, Inc. | +1.2% | +69.06% | Add |
| 9 | ✓ | +0.9% | +21.46% | Add | |
| 10 | KDMN | Kadmon Holdings INC | +0.6% | -0.21% | Trim |
| 11 | RTRXEUR | Retrophin INC | +0.5% | — | Unchanged |
| 12 | ✓ | Liminal Biosciences INC | 0% | — | Unchanged |
| 13 | OVID | Ovid Therapeutics INC | -0.2% | -10.66% | Trim |
| 14 | APLSUSD | Apellis Pharmaceuticals INC | -0.2% | -92.59% | Trim |
| 15 | BEATEUR | Biotelemetry INC | -0.3% | -68.25% | Trim |
| 16 | QURE | uniQure N.V. | -0.4% | +11.15% | Add |
| 17 | AXGN | Axogen INC | -0.5% | +19.41% | Add |
| 18 | ADMA | Adma Biologics INC | -0.5% | -34.52% | Trim |
| 19 | AUPH | Aurinia Pharmaceuticals INC | -0.7% | +4.28% | Add |
| 20 | OPHTEUR | Iveric Bio INC | -1% | -8.05% | Trim |
| 21 | OXLC | Oxford Lane Capital Corp. | -1.5% | -47.35% | Trim |
| 22 | ITCIEUR | Intra-cellular Therapies INC | -2.3% | -16.22% | Trim |
| 23 | EPZMEUR | Epizyme INC | -2.7% | -23.26% | Trim |
| 24 | ARQLUSD | Arqule INC | — | EXIT | Sold out |
| 25 | ALGN | Align Technology INC | — | EXIT | Sold out |
| 26 | GWPH | Gw Pharmaceuticals LTD | — | EXIT | Sold out |
| 27 | AKBA | Akebia Therapeutics INC | — | NEW | New buy |
| 28 | EXK | Exact Sciences CORP | — | EXIT | Sold out |
| 29 | IOVA | Iovance Biotherapeutics INC | — | EXIT | Sold out |
| 30 | PRNB | Principia Biopharma INC | — | NEW | New buy |
| 31 | CYTK | Cytokinetics INC | — | NEW | New buy |
| 32 | KNSA | Kiniksa Pharmaceuticals International, plc | — | NEW | New buy |
| 33 | TNDM | Tandem Diabetes Care INC | — | EXIT | Sold out |
| 34 | CHRS | Coherus Oncology INC | — | NEW | New buy |
| 35 | VCEL | Vericel CORP | — | EXIT | Sold out |
| 36 | PODD | Insulet CORP | — | EXIT | Sold out |
| 37 | XENE | Xenon Pharmaceuticals INC | — | NEW | New buy |
| 38 | BLU | Bellus Health INC | — | NEW | New buy |
| 39 | STAA | Staar Surgical Co | — | EXIT | Sold out |
| 40 | ✓ | Axovant Gene THE | — | NEW | New buy |
| 41 | AM6 | Amicus Therapeutics INC | — | EXIT | Sold out |
| 42 | TPB | Turning Point Brands, Inc. | — | EXIT | Sold out |
| 43 | MOR2 | Morphosys AG Adr | — | EXIT | Sold out |